Venous Thromboembolism: A-V Foot Pumps in the Prophylaxis of DVT/PE--old

Archived PMG

Published 1998
Citation: J Trauma. 53(1):142-164, July 2002.

Download

Authors

EAST Practice Parameter Workgroup for DVT Prophylaxis

Frederick B. Rogers, MD, FACS
University of Vermont Department of Surgery
Director of Trauma and Critical Care
Fletcher Allen Heath Care
Burlington, VT

Mark D. Cipolle, MD, Ph.D.
Surgical Practice Center
Allentown, PA

George Velmahos, MD, Ph.D.
Department of Surgery, Division of Trauma and Critical Care
University of Southern California
Los Angeles, CA

Grace Rozycki, MD
Emory USM, Department of Surgery
Atlanta, GA

I. Statement of the Problem

Gardner and Fox,[1] in 1983, discovered a venous pump on the sole of the foot that consists of a plexus of veins that fills by gravity and empties upon weightbearing, thus increasing femoral blood flow without muscular assistance. A mechanical device, the A-V foot pump, has been developed to mimic this effect of weightbearing.The major advantage of this system is that it only requires access to the foot, which enables it to be used in patients with Jones dressings, casts, or externally fixed limbs that previously were unsuitable for SCD. One study has shown that the pulsatile action of the A-V foot pump increased venous blood flow velocity in the popliteal vein by 250%.[2]

II. Process

With the recent clinical introduction of the A-V foot pump, there is a paucity of relevant literature related to this subject. A Medline review dating back to 1980 revealed 12 articles on A-V foot pumps.There were eight articles specifically related to the use of A-V foot pumps in the trauma patient.

III. Recommendations

A. Level I

There are insufficient data to suggest Level I recommendations for this topic.

B. Level II

There are insufficient data to suggest Level II recommendations for this topic.

C. Level III

A-V foot pumps may be used as a substitute for sequential compression devices (SCDs) in those high risk trauma patients who cannot wear SCDs due to external fixators or casts.

IV. Scientific Foundation

Most of the studies involving the use of A-V foot pumps are found in the orthopaedic literature, and many of these series involve small numbers of patients. Bradley et al.[3] in a randomized prospective trial of 74 patients undergoing total hip replacement assessed the additive effect of A-V impulse venous foot pump to prophylaxis with graduated compression stockings plus LDH plus hydroxychloroquine. All patients were submitted to bilateral ascending venography on the 12th postoperative day.The incidence of DVT was 6.6% in the pumped group and 27.3% (p<0.025) in the non-pumped group.Two patients developed pressure sores due to ill-fitting slippers in the pumped group. Stranks et al.,[4] in a randomized prospective trial of 82 patients treated for subcapital fractures, compared the A-V foot pump to no DVT prophylaxis.The incidence of DVT as assessed by Doppler ultrasound was 23% in the control group and 0% in those using the device (p<0.0001). Postoperative swelling was also decreased significantly in the treatment group as manifested by a decreased thigh circumference of 3.27cm (p<0.001) and thigh circumference of 1.55cm (p<0.001) in the pumped group relative to the control group. This study suffers somewhat in its design in that a control group which received no prophylaxis is probably not considered a standard treatment for hip fractures with its well known high propensity to develop venous thromboembolism complications. In addition, the comparability of the groups was not presented, and 93% of the DVTs were proximal (this is not sensible).A better comparison would be to compare A-V foot pumps to standard DVT prophylaxis such as subcutaneous heparin.Such a study was done by Santori et al.[12] in 132 patients randomized to receive heparin vs. A-V footpumps.DVT was diagnosed in 23 patients (35.4%) in the heparin group vs. 9 (13.4%) in the A-V impulse group (p<0.005).In the heparin group there was one fatal PE, and 9 patients had excessive bleeding (13.8%) vs. none in the impulse group.Potential problems with this study include 1) the use of thermography and Doppler ultrasound as outcome measures, 2) the biased application of venography (48% vs 25% of patients), 3) unblinded DVT assessment, and 4) an unblinded bleeding assessment.

Fordyce and Ling[5] in a similar randomized prospective study compared the use of TED stockings with the A-V impulse system in 84 patients undergoing total hip replacement. Venographically-proved DVT was 40% in the TED group and 5% in the pumped group (p<0.001).Again, the study design was flawed in not providing more aggressive DVT prophylaxis in the control group. Also, they used only unilateral venography which underestimates the true DVT rates. In another prospective study [6] that included 59 patients undergoing elective knee replacement, venography showed a 19% incidence of proximal DVT in the control group and 0% in the group treated with A-V foot pumps.Westrich and Sculco[11] in a Level I study, compared 122 patients (164 knees) scheduled to undergo unilateral or bilateral knee replacement and were randomized to receive either aspirin alone or A-V foot pumps and aspirin.The prevalence of DVT was 27% (22 of 81 knees) in the A-V foot pump group vs. 59% (49 of 83 knees) in the aspirin group (p>0.0 01).Of note, no proximal thrombi were noted in any patient using the A-V foot pump vs. a 14% incidence (p< 0.0003) of popliteal or femoral DVT in the aspirin treated group. The authors also demonstrated that the total duration of time that the device wa s worn was related to whether or not the patient developed a DVT. Patients in whom a DVT did not develop used the device for a mean time of 96±23.4 hours while those who developed a DVT wore the device for 67±21.1 hours (p<0.001).

Although little has been done on the effects of the A-V impulse system on DVT in trauma patients, other beneficial effects have been observed. In 71 patients who had operations or casts for traumatic lower extremity injuries, Gardner and Fox[7] showed a significant decrease in pain, swelling and measurement of compartment pressures in the affected extremities with the use of the A-V foot pumps.In the discussion to this paper, the authors hypothesized that the increased blood flow seen with the pumps is due to hyperemia mediated by endothelial-derived-relaxing factor (EDRF) which is liberated by the endothelium secondary to sudden pressure changes such as could be caused by the A-V pumps.This EDRF release could encourage the opening of critically closed capillaries, enabling reabsorption of fluid, hence the decrease in compartment pressures.In addition, there have been reports of A-V foot pumps improving arterial blood flow with the relief of ischemic rest pain.[8] [9] In a recently prospective randomized study by Knudson et al.,[10] A-V foot pumps were one arm of a number of prophylactic measures (low molecular weight heparin and sequential pneumatic compression devices were the other arms) used to prevent DVT in high risk trauma patients. Of 372 patients enrolled in the study, the DVT rate was 5.7% for the A-V foot pumps, 2.5% for the SCDs and 0.8% for the low -molecular weight heparin as determined on follow-up serial duplex ultrasound.Of note, severe skin changes, including blistering and wound problems, occurred in 8/53 patients who wore the foot pumps.This required three patients to be removed early from the study because of wound and skin problems.

Spain et al[13] compared the use of A-V foot pumps to SCD in 184 consecutively injured patients.In this non-randomized study, patients who could not receive SCD because of lower extremity injuries were placed in A-V foot pumps. Overall, there was no significant difference in DVT rates between the two groups with SCD at 7% and A-V foot pumps at 3%.The authors of this study conc luded that A-V foot pumps were a reasonable alternative to SCD when lower extremity fractures preclude the use of SCD. Anglen et al[14] performed a randomized prospective trial comparing A-V foot pumps with SCE in high-risk orthopedic patients and followed them with serial ultrasound.In 124 patients, the overall incidence of DVT was 4% in the A-V foot pumps and 0% in the SCD. Unfortunately, meaningful analysis of such a study was confounded by the heterogeneity of the two groups, and the fact that a siza ble number of patients received either aspirin or warfarin postop. In another study by Anglen et al[15] in a trauma population of ICU and ward patients, the A-V foot pumps were found to be applied properly and functioning correctly 59% of the time, a similar problem to that reported by Comerota et al[16] for SCD.

V. Summary

Small clinical series inelectiveorthopaedic patients support the use of A-V foot pumps to prevent DVT.Only one clinical series in trauma patients compares A-V foot pumps to other stan dard techniques of DVT prophylaxis. The results from this series are not definitive in terms of the benefits of A-V foot pumps in preventing DVT. However, there is a theoretical advantage for the use of A-V foot pumps in the high-risk trauma patient who has a contraindication to heparin because of their injuries and who cannot have SCDs placed on lower extremities secondary to external fixators or large bulky dressings.

VI. Future Investigations

More prospective, randomized studies are needed comparing A-V foot pumps to standard prophylactic measures in trauma patients at high risk for the development of DVT.

VII. References

  1. Gardner AMN, Fox RH: The venous pump of the human foot --preliminary report. Bristol Medico-Chirurgical J 98:109-12, 1983
  2. Laverick MD, McGivern RC, Crone MD, Mollan RAB: A comparison of the effects of electrical calf muscle stimulation and the venous foot pump on venous blood flow in the lower leg.Phlebology 5:285­90, 1990
  3. Bradley JG, Krugener GH, Jager HJ: The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty: A randomized prospective trial. J Arthroplasty 8:57-61, 1993
  4. Stranks GJ, MacKenzie NA, Grover ML, Fail T: The A-V Impulse System reduces deep-vein thrombosis and swelling after hemiarthroplasty for hip fracture. J Bone Joint Surg 74B:775-8, 1992
  5. Fordyce MJ, Ling RS: A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg 74B:45-9, 1992
  6. Wilson NV, Das SK, Kakkar VV, et al: Thrombo-embolic prophylaxis in total knee replacement. Evaluation of the A-V impulse system. J Bone Joint Surg 74B:50-2, 1992
  7. Gardner AM, Fox RH, Lawrence C, et al: Reduction of post-traumatic swelling and compartment pressure by impulse compression of the foot. J Bone Joint Surg 72B:810-5, 1990
  8. Morgan RH, Carolan G, Psaila JV, et al: Arterial flow enhancement by impulse compression.Vasc Surg 25:8-15, 1991
  9. Abu-Own A, Cheatle T, Scurr JH, et al: Effects of intermittent pneumatic compression of the foot on microcirculatory function in arterial disease. Eur J Vasc Surg 7:488-92, 1993
  10. Knudson MM, Morabito D, Paiement GD, et al: Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma 41:446-59, 1996
  11. Westrich GH, Sculco TP: Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg 78A:826-34, 1996.
  12. Santori FS, Vitullo A, Stopponi M, et al: Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump. J Bone Joint Surg 76B:579-83, 1994
  13. Spain DA, Bergamini, Hoffman JF, et al. Comparison of sequential compression devices and foot pumps for prophylaxis of deep venous thrombosis in high-risk trauma patients. Am Surg64:522­526,1998
  14. Anglen JO, Bagby C, George R: A randomized comparison of sequential-gradient calf compression with intermittent plantar compression for prevention of venous thrombosis in orthopedic trauma patients: preliminary results. Am J Ortho 33:53-57, 1998.
  15. Anglen JO, Goss K, Edwards J, Heickfeldt RE: Foot pump prophylaxis for deep venous thrombosis: the rate of effective usage in trauma patients. Am J Ortho :580-582, 1998
  16. Comerota AJ, Katz ML, White JV: Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg 164:265-8, 1992

Table

Deep Venous Thrombosis (DVT) in Trauma: A Literature Review

A-V Foot Pumps

First Author Year Reference Title Class Conclusions

Gardner AMN

1983

The venous pump of the human foot — preliminary report.

Bristol Medico-Chirurgical J 98:109-12

III

First description of the physiologic pumping mechanism on the sole of the foot.

Laverick MD

1990

A comparison of the effects of electrical calf muscle stimulation and the venous foot pump on venous blood flow in the lower leg. Phlebography 5:285-90

III

This study demonstrated that A -V foot pump increases venous blood flow in popliteal vein by 250%.

Bradley JC

1993

The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty: A randomized prospective trial.

J Arthroplasty 8:57-61

II

74 patients undergo ing total hip replacement compared SQ heparin to A -V foot pumps. SQ heparin - 27% DVT vs A-V foot pump - 6.6% DVT.

Stranks GJ

1992

The A-V Impulse System reduces deep-vein thrombosis and swelling after hemiarthroplasty for hip fracture.

J Bone Joint Surg 74B:775-78

II

Prospective randomized trial of TED stockings ± A -V foot pumps.  Control group had 23% DVT rate vs 0% in the A -V foot pump group.

Fordyce MJ

1992

A venous foot pump reduces thrombosis after total hip replacement.

J Bone Joint Surg 74B:45-9

II

Randomized, controlled study of 84 patients with TED vs TED & A -V foot pump. Venography follow-up revealed 10% DVT rate in A -V foot pumped group and 40% in controls.

Wilson NV

1992

Thrombo-embolic prophylaxis in total knee replacement. Evaluation of the A -V impulse system.

J Bone Joint Surg 74B:50-2

II

Prospective trial of 59 patients with no prophylaxis vs A -V foot pumps.  Control DVT rate was 68.7% and A-V foot pump was 50% detected by venography, with major DVT in 59% vs 18%, respectiv ely.

Gardner AM

1990

Reduction of post-traumatic swelling and compartment pressure by impulse compression of the foot.

J Bone Joint Surg 72B:810-5

III

Multicenter trial showe d decrease in pain and compartment pressures with the use of A-V foot pumps.  Hypothesized that this was due to release of endothelial-derived relaxing factor in microcirculation.

Morgan RH

1991

Arterial flow enhanced by impulse compression.

Vasc Surg 25:8-15

III

22 patients with peripheral vascular disease had relief of ischemic rest pain with use of A-V foot pump.

Abu-Own A

1993

Effects of intermittent pneumatic compression of the foot on the microcirculatory function in arterial disease.

Eur J Vasc Surg 7:488-92

III

A-V foot pumps increased transcutaneous oxygen and laser Doppler fluxemetry in patients with severe claudication.

Knudson MM

1996

The use of low molecular weight heparin in preventing thromboembolism in trauma patients.

J Trauma 41:446-59

II

A-V foot pumps used as one limb of prospective study on DVT prophylaxis. Foot pumps had a higher DVT rate (not significant) than LMWH or SCD, and there were complications with their use.

Westrich GH

1996

Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone.

J Bone Joint Surg 78A:826-33

I

122 patients (164 knees) compared DVT with A -V foot pumps and aspirin (27%) vs aspirin alone (59%; p<0.001). No proximal DVT occurred with A-V foot pumps vs 14% with aspirin (p<0.0003).  Length of time foot pump was used significant for development of DVT. Patients with no DVT wore foot pump for 96±23.4 hours. Patients with DVT wore foot pump for 67±21.1 hours (p<0.001).

Santori FS

1994

Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump.

J Bone Joint Surg 76B:579-83

I

132 patients randomized to receive subcutaneous heparin vs A -V foot pump with 35.4% vs 13.4% incidence of DVT (p<0.005).  There was one fatal PE and nine patients (13.8%) with excessive bleeding in the heparin group vs none in the A -V foot pump group.

Spain DA

1998

Comparison of sequential compression devices and foot pumps for prophylaxis of deep venous thrombosis in high-risk trauma patients. 

Am Surg 64:522-526

III

Non-randomized study of 184 high risk patients, incidence of DVT was similar between groups (7% SCD; 3% A -V foot pumps) as was number of Pes (2 AV foot pumps, 1 SCD)

Anglen JO

1998

A randomized comparison of sequential -gradient calf compression with intermittent plantar compression for prevention of venous thrombosis in orthopedic trauma patients: preliminary results.

Am J Ortho 33:53-57.

II

Prospective, randomized controlled study of high risk or the patients followed with serial Duplex. DVT rates: 0% SCD

4% A – V foot pump

Anglen JO

1998

Foot pump prophylaxis for deep venous thrombosis: the rate of effective usage in trauma patients.

Am J Ortho :580-582, 1998

III

Trauma population found that A – V footpumps were applied properly and

functioning only 59% of the time.

Comerota AJ

1992

Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?

Am J Surg 164:265-8, 1992

III

A-V foot pumps increased transcutaneous oxygen and laser Doppler fluxemetry in patients with severe claudication.

 

« Back to guidelines